Compare iShares Bitcoin Trust (IBIT) vs Stryker Corporation (SYK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares Bitcoin Trust vs Stryker Corporation — how do they compare? iShares Bitcoin Trust trades at $35.87, while Stryker Corporation trades at $346.82 (market cap $133.54B). The key difference: Stryker Corporation pays a 1.01% dividend while iShares Bitcoin Trust pays none, and Stryker Corporation is trading nearer its 52-week high, iShares Bitcoin Trust nearer its low. Which is the better fit depends on your goals.
| IBIT | SYK | |
|---|---|---|
Sector | Crypto-linked | Technology |
52-Week High | $71.29 | $394.34 |
52-Week Low | $33.29 | $282.58 |
Market Cap | — | $133.54B |
Enterprise Value | — | $145.01B |
Dividend Yield | — | 1.01% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IBIT trades at $35.89, down 0.94% with bearish technical signals from moving averages. The stock faces selling pressure but shows neutral oscillator readings. Recent news highlights institutional interest with Alpha Zero LLC increasing its position by 43.8% in Q1 2026 (SEC filing, 2026-07-21). Bitcoin ETF flows show selective demand, with IBIT leading recent inflows after seven straight days of buying (ETF Trends, 2026-07-23).
The outlook remains cautious due to technical bearishness and Bitcoin's 44% decline from 2025 peaks. Long-term potential exists from institutional adoption, but investors face volatility risks. Analyst sentiment is mixed, with some recommending accumulation for long-term holders while technical indicators suggest near-term pressure.
Stryker (SYK) trades at $347.21, up 0.4% today, with a bullish technical outlook supported by moving averages. The stock shows strong fundamentals, including a 9% organic sales growth in Q2 2026 and a net income margin of 14.43%. Recent news highlights recovery from a cybersecurity incident and the launch of Mako RPS, expanding its robotic surgery portfolio. Analyst consensus is overwhelmingly positive, with 74% recommending Buy and a price target of $379.44.
The outlook for SYK is favorable, driven by robust earnings growth and strategic product launches. Key risks include cybersecurity vulnerabilities and margin pressures from tariffs. With no sell ratings and strong institutional support, the stock presents a compelling opportunity for growth-oriented investors, though monitoring quarterly execution remains critical.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About iShares Bitcoin Trust
IBIT is a spot Bitcoin ETF that tracks the price of Bitcoin directly. Managed by BlackRock, it offers investors a regulated way to gain exposure to the digital asset within a traditional brokerage account.
Read more on IBIT →About Stryker Corporation
Stryker is a global leader in medical technology, specializing in Orthopaedics, MedSurg, and Neurotechnology. It is renowned for its highly decentralized business model, which empowers 22 specialized business units to drive innovation and category leadership. With its market-leading Mako SmartRobotics™ platform and a relentless M&A strategy, Stryker provides a comprehensive ecosystem of connected surgical tools, implants, and digital solutions that improve both clinical and financial outcomes for hospitals worldwide.
Read more on SYK →
